The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States and is the country’s fifth most common cause of cancer mortality in women. A major challenge in treating ovarian cancer is that most patients have advanced disease at initial diagnosis. These NCCN Guidelines discuss cancers originating in the ovary, fallopian tube, or peritoneum, as these are all managed in a similar manner. Most of the recommendations are based on data from patients with the most common subtypes─high-grade serous and grade 2/3 endometrioid. The NCCN Guidelines also include recommendations specifically for patients with less common ovarian cancers, which in the guidelines include the following: carcinosarcoma, clear cell carcinoma, mucinous carcinoma, low-grade serous, grade 1 endometrioid, borderline epithelial, malignant sex cord-stromal, and malignant germ cell tumors. This manuscript focuses on certain aspects of primary treatment, including primary surgery, adjuvant therapy, and maintenance therapy options (including PARP inhibitors) after completion of first-line chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Self-citationMaintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Moore, K., Colombo, N., Scambia, G., Kim, B.-G., Oaknin, A., Friedlander, M., Lisyanskaya, A., Floquet, A., Leary, A., Sonke, G. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1810858 · Cited by 2,870
Self-citationMcGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,625
Self-citationNeoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Vergote, I., Tropé, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., Verheijen, R. H. M., van der Burg, M. E. L., Lacave, A. J., Panici, P. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908806 · Cited by 2,537
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Burger, R. A., Brady, M. F., Bookman, M. A., Fleming, G. F., Monk, B. J., Huang, H., Mannel, R. S., Homesley, H. D., Fowler, J., Greer, B. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104390 · Cited by 2,404
Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L., & Montz, F. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1248 · Cited by 2,312
Self-citationAudeh, M. W., Carmichael, J., Penson, R. T., Friedlander, M., Powell, B., Bell-McGuinn, K. M., Scott, C., Weitzel, J. N., Oaknin, A., Loman, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60893-8 · Cited by 2,279
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
González-Martín, A., Pothuri, B., Vergote, I., DePont Christensen, R., Graybill, W., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910962 · Cited by 2,263
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103799 · Cited by 2,172
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Ray-Coquard, I., Pautier, P., Pignata, S., Pérol, D., González-Martín, A., Berger, R., Fujiwara, K., Vergote, I., Colombo, N., Mäenpää, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911361 · Cited by 2,055
Ozols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., Mannel, R. S., DeGeest, K., Hartenbach, E. M., & Baergen, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.153 · Cited by 2,032
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105535 · Cited by 1,883
Self-citationPujade-Lauraine, E., Ledermann, J. A., Selle, F., Gebski, V., Penson, R. T., Oza, A. M., Korach, J., Huzarski, T., Poveda, A., Pignata, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30469-2 · Cited by 1,855
Self-citationFertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., Taylor, H. S., Wallace, W. H., Wang, E. T., & Loren, A. W. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.1914 · Cited by 1,486
Kehoe, S., Hook, J., Nankivell, M., Jayson, G. C., Kitchener, H., Lopes, T., Luesley, D., Perren, T., Bannoo, S., Mascarenhas, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62223-6 · Cited by 1,414
Alberts, D. S., Liu, P. Y., Hannigan, E. V., O'Toole, R., Williams, S. D., Young, J. A., Franklin, E. W., Clarke-Pearson, D. L., Malviya, V. K., DuBeshter, B., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352603 · Cited by 1,228
Telli, M. L., Timms, K. M., Reid, J., Hennessy, B., Mills, G. B., Jensen, K. C., Szallasi, Z., Barry, W. T., Winer, E. P., Tung, N. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2477 · Cited by 1,136
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
du Bois, A. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg036 · Cited by 1,113
Ledermann, J. A., Raja, F. A., Fotopoulou, C., Gonzalez-Martin, A., Colombo, N., & Sessa, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt333 · Cited by 1,104
Fong, P. C., Yap, T. A., Boss, D. S., Carden, C. P., Mergui-Roelvink, M., Gourley, C., De Greve, J., Lubinski, J., Shanley, S., Messiou, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9589 · Cited by 1,010
Piccart, M. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.699 · Cited by 981
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
Coleman, R. L., Fleming, G. F., Brady, M. F., Swisher, E. M., Steffensen, K. D., Friedlander, M., Okamoto, A., Moore, K. N., Efrat Ben-Baruch, N., Werner, T. L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1909707 · Cited by 913
Self-citationOza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00086-8 · Cited by 875
Abkevich, V, Timms, K. M., Hennessy, B. T., Potter, J., Carey, M. S., Meyer, L. A., Smith-McCune, K., Broaddus, R., Lu, K. H., Chen, J., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.451 · Cited by 815
Katsumata, N., Yasuda, M., Takahashi, F., Isonishi, S., Jobo, T., Aoki, D., Tsuda, H., Sugiyama, T., Kodama, S., Kimura, E., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61157-0 · Cited by 727
Bookman, M. A., Brady, M. F., McGuire, W. P., Harper, P. G., Alberts, D. S., Friedlander, M., Colombo, N., Fowler, J. M., Argenta, P. A., De Geest, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1684 · Cited by 705
Trimbos, J. B., Vergote, I., Bolis, G., Vermorken, J. B., Mangioni, C., Madronal, C., Franchi, M., Tateo, S., Zanetta, G., Scarfone, G., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.113 · Cited by 674
Popova, T., Manié, E., Rieunier, G., Caux-Moncoutier, V., Tirapo, C., Dubois, T., Delattre, O., Sigal-Zafrani, B., Bollet, M., Longy, M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1470 · Cited by 665
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
Birkbak, N. J., Wang, Z. C., Kim, J.-Y., Eklund, A. C., Li, Q., Tian, R., Bowman-Colin, C., Li, Y., Greene-Colozzi, A., Iglehart, J. D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0206 · Cited by 661
Vasey, P. A., Jayson, G. C., Gordon, A., Gabra, H., Coleman, R., Atkinson, R., Parkin, D., Paul, J., Hay, A., Kaye, S. B., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh323 · Cited by 632
Vergote, I., De Brabanter, J., Fyles, A., Bertelsen, K., Einhorn, N., Sevelda, P., Gore, M. E., Kærn, J., Verrelst, H., Sjövall, K., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03590-x · Cited by 623
Muggia, F. M., Braly, P. S., Brady, M. F., Sutton, G., Niemann, T. H., Lentz, S. L., Alvarez, R. D., Kucera, P. R., & Small, J. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.106 · Cited by 601
Self-citationA Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
Harter, P., Sehouli, J., Lorusso, D., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1808424 · Cited by 594
Chi, D. S., Eisenhauer, E. L., Zivanovic, O., Sonoda, Y., Abu-Rustum, N. R., Levine, D. A., Guile, M. W., Bristow, R. E., Aghajanian, C., & Barakat, R. R. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.03.018 · Cited by 591
Self-citationYoung, R. C., Walton, L. A., Ellenberg, S. S., Homesley, H. D., Wilbanks, G. D., Decker, D. G., Miller, A., Park, R., & Major, F. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004123221501 · Cited by 583
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Peres, L. C., Cushing-Haugen, K. L., Köbel, M., Harris, H. R., Berchuck, A., Rossing, M. A., Schildkraut, J. M., & Doherty, J. A. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy071 · Cited by 554
Self-citationFinal Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Tewari, K. S., Burger, R. A., Enserro, D., Norquist, B. M., Swisher, E. M., Brady, M. F., Bookman, M. A., Fleming, G. F., Huang, H., Homesley, H. D., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01009 · Cited by 483
Katsumata, N., Yasuda, M., Isonishi, S., Takahashi, F., Michimae, H., Kimura, E., Aoki, D., Jobo, T., Kodama, S., Terauchi, F., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70363-2 · Cited by 480
Panici, P. B., Maggioni, A., Hacker, N., Landoni, F., Ackermann, S., Campagnutta, E., Tamussino, K., Winter, R., Pellegrino, A., Greggi, S., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji102 · Cited by 465
Neijt, J. P., Engelholm, S. A., Tuxen, M. K., Sørensen, P. G., Hansen, M., Sessa, C., de Swart, C. A. M., Hirsch, F. R., Lund, B., & van Houwelingen, H. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3084 · Cited by 428
Timms, K. M., Abkevich, V., Hughes, E., Neff, C., Reid, J., Morris, B., Kalva, S., Potter, J., Tran, T. V., Chen, J., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0475-x · Cited by 419
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
Earle, C. C., Schrag, D., Neville, B. A., Yabroff, K. R., Topor, M., Fahey, A., Trimble, E. L., Bodurka, D. C., Bristow, R. E., Carney, M., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj019 · Cited by 416
Optimal primary surgical treatment for advanced epithelial ovarian cancer
Elattar, A., Bryant, A., Winter-Roach, B. A., Hatem, M., & Naik, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007565.pub2 · Cited by 403
Fagotti, A., Ferrandina, G., Vizzielli, G., Fanfani, F., Gallotta, V., Chiantera, V., Costantini, B., Margariti, P. A., Gueli Alletti, S., Cosentino, F., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.01.017 · Cited by 395
Pignata, S., Scambia, G., Katsaros, D., Gallo, C., Pujade-Lauraine, E., De Placido, S., Bologna, A., Weber, B., Raspagliesi, F., Panici, P. B., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70049-x · Cited by 389
Nishino, M., Jagannathan, J. P., Ramaiya, N. H., & Van den Abbeele, A. D. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.4110 · Cited by 378
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
Bristow, R. E., Puri, I., & Chi, D. S. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.033 · Cited by 374
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
Chan, J. K., Brady, M. F., Penson, R. T., Huang, H., Birrer, M. J., Walker, J. L., DiSilvestro, P. A., Rubin, S. C., Martin, L. P., Davidson, S. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505067 · Cited by 367
Self-citationEisenhauer, E. L., Abu‐Rustum, N. R., Sonoda, Y., Levine, D. A., Poynor, E. A., Aghajanian, C. A., Jarnagin, W. R., DeMatteo, R. P., D'Angelica, M. I., Barakat, R. R., et al. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.028 · Cited by 366
Self-citationWright, A. A., Bohlke, K., Armstrong, D. K., Bookman, M. A., Cliby, W. A., Coleman, R. L., Dizon, D. S., Kash, J. J., Meyer, L. A., Moore, K. N., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.05.022 · Cited by 362
Self-citationAlberts, D. S., Green, S., Hannigan, E. V., O’Toole, R. V., Stock-Novack, D., Anderson, P., Surwit, E. A., Malvlya, V. K., Nahhas, W. A., & Jolles, C. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.706 · Cited by 317
PARP inhibitors in the Management of Ovarian Cancer: ASCO guideline
Tew, W. P., Lacchetti, C., Ellis, A., Maxian, K., Banerjee, S., Bookman, M., Jones, M. B., Lee, J.-M., Lheureux, S., Liu, J. F., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01924 · Cited by 315
Self-citationFagotti, A., Ferrandina, G., Fanfani, F., Garganese, G., Vizzielli, G., Carone, V., Salerno, M. G., & Scambia, G. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.052 · Cited by 315
Bell, J., Brady, M. F., Young, R. C., Lage, J., Walker, J. L., Look, K. Y., Rose, G. S., & Spirtos, N. M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.013 · Cited by 307
Marquard, A. M., Eklund, A. C., Joshi, T., Krzystanek, M., Favero, F., Wang, Z. C., Richardson, A. L., Silver, D. P., Szallasi, Z., & Birkbak, N. J. (2015) · Biomarker Research · doi:10.1186/s40364-015-0033-4 · Cited by 305
Tewari, D., Java, J. J., Salani, R., Armstrong, D. K., Markman, M., Herzog, T., Monk, B. J., & Chan, J. K. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9898 · Cited by 288
Self-citationSchilder, J. M., Thompson, A. M., DePriest, P. D., Ueland, F. R., Cibull, M. L., Kryscio, R. J., Modesitt, S. C., Lu, K. H., Geisler, J. P., Higgins, R. V., et al. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6805 · Cited by 263
Hershman, D. L., Till, C., Wright, J. D., Awad, D., Ramsey, S. D., Barlow, W. E., Minasian, L. M., & Unger, J. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.66.2346 · Cited by 246
Walker, J. L., Brady, M. F., Wenzel, L., Fleming, G. F., Huang, H. Q., DiSilvestro, P. A., Fujiwara, K., Alberts, D. S., Zheng, W., Tewari, K. S., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01568 · Cited by 231
Self-citationNorquist, B. M., Brady, M. F., Harrell, M. I., Walsh, T., Lee, M. K., Gulsuner, S., Bernards, S. S., Casadei, S., Burger, R. A., Tewari, K. S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1327 · Cited by 230
Pignata, S., Scambia, G., Ferrandina, G., Savarese, A., Sorio, R., Breda, E., Gebbia, V., Musso, P., Frigerio, L., Del Medico, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8566 · Cited by 229
Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality Care
Bristow, R. E., Chang, J., Ziogas, A., & Anton-Culver, H. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182922a17 · Cited by 222
Satoh, T., Hatae, M., Watanabe, Y., Yaegashi, N., Ishiko, O., Kodama, S., Yamaguchi, S., Ochiai, K., Takano, M., Yokota, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.8617 · Cited by 211
Pfisterer, J., Weber, B., Reuss, A., Kimmig, R., du Bois, A., Wagner, U., Bourgeois, H., Meier, W., Costa, S., Blohmer, J.-U., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj296 · Cited by 211
Clamp, A. R., James, E. C., McNeish, I. A., Dean, A., Kim, J.-W., O'Donnell, D. M., Hook, J., Coyle, C., Blagden, S., Brenton, J. D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32259-7 · Cited by 209
Friedlander, M., Matulonis, U., Gourley, C., du Bois, A., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0271-y · Cited by 185
Self-citationChi, D. S., Abu-Rustum, N. R., Sonoda, Y., Ivy, J., Rhee, E., Moore, K., Levine, D. A., & Barakat, R. R. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.018 · Cited by 183
Eisenhauer, E. L., Abu-Rustum, N. R., Sonoda, Y., Aghajanian, C., Barakat, R. R., & Chi, D. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.10.022 · Cited by 178
Self-citationBolis, G., Colombo, N., Pecorelli, S., Torri, V., Marsoni, S., Bonazzi, C., Chiari, S., Favalli, G., Mangili, G., Presti, M., et al. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059355 · Cited by 169
Chan, J. K., Tian, C., Fleming, G. F., Monk, B. J., Herzog, T. J., Kapp, D. S., & Bell, J. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.10.073 · Cited by 167
Hakes, T. B., Chalas, E., Hoskins, W. J., Jones, W. B., Markman, M., Rubin, S. C., Chapman, D., Almadrones, L., & Lewis, J. L. (1992) · Gynecologic Oncology · doi:10.1016/0090-8258(92)90305-3 · Cited by 162
Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial
Guidozzi, F., & Daponte, A. I. (1999) · Cancer · Cited by 160
Lee, I.-H., Choi, C. H., Hong, D. G., Song, J. Y., Kim, Y. J., Kim, K. T., Lee, K. W., Park, I. S., Bae, D. S., & Kim, T. J. (2011) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2011.22.3.188 · Cited by 154
Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival
Cliby, W. A., Powell, M. A., Al-Hammadi, N. J., Chen, L., Miller, J. P., Roland, P. Y., Mutch, D. G., & Bristow, R. E. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.10.023 · Cited by 153
Self-citationFertility preservation in young women with epithelial ovarian cancer
Wright, J. D., Shah, M. M., Mathew, L., Burke, W. M., Culhane, J. F., Goldman, N. A., Schiff, P. B., & Herzog, T. J. (2009) · Cancer · doi:10.1002/cncr.24461 · Cited by 150
Landrum, L. M., Java, J., Mathews, C. A., Lanneau, G. S., Copeland, L. J., Armstrong, D. K., & Walker, J. L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.04.001 · Cited by 149
Self-citationFagotti, A., Vizzielli, G., Iaco, P. D., Surico, D., Buda, A. A., Mandato, V. D., Petruzzelli, F., Ghezzi, F., Garzarelli, S., Mereu, L., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.07.016 · Cited by 149
Rutten, M. J., van Meurs, H. S., van de Vrie, R., Gaarenstroom, K. N., Naaktgeboren, C. A., Gorp, T. V., ter Brugge, H. G., Hofhuis, W., Schreuder, H. W. R., Arts, H. J. G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.2962 · Cited by 148
Tewari, K. S., Java, J., Eskander, R. N., Monk, B. J., & Burger, R. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv500 · Cited by 140
Gadducci, A., Carnino, F., Chiara, S., Brunetti, I. M., Tanganelli, L., Romanini, A., Bruzzone, M., & Conte, P. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5677 · Cited by 140
Eeles, R. A., Morden, J. P., Gore, M. E., Mansi, J., Glees, J. P., Wenczl, M., Williams, C. M., Kitchener, H. C., Osborne, R. H., Guthrie, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.9719 · Cited by 140
Stark, D., Nankivell, M. G., Pujade-Lauraine, É., Kristensen, G. B., Elit, L., Stockler, M. R., Hilpert, F., Cervantes, A. M. R., Brown, J. M., Lanceley, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70567-3 · Cited by 137
DiSilvestro, P., Colombo, N., Scambia, G., Kim, B., Oaknin, A., Friedlander, M. L., Lisyanskaya, A. S., Floquet, A., Leary, A. F., Sonke, G. S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00799 · Cited by 132
Self-citationBristow, R. E., Chang, J. J., Ziogas, A., Campos, B., Chávez, L. R., & Anton‐Culver, H. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.01.056 · Cited by 121
Lambert, H. E., Rustin, G. J. S., Gregory, W. M., & Nelstrop, A. E. (1997) · Annals of Oncology · doi:10.1023/a:1008256431090 · Cited by 119
Schüring, A. N., Fehm, T. N., Behringer, K., Goeckenjan, M., Wimberger, P., Henes, M., Henes, J., Fey, M. F., & von Wolff, M. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4594-3 · Cited by 116
Fertility Preservation in Women
van den Heuvel‐Eibrink, M. M., van der Kooi, A.-L. L. F., & Wallace, W. H. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1715731 · Cited by 115
Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis
Park, H. J., Kim, D., Yim, G. W., Nam, E. J., Kim, S., & Kim, Y. T. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.04.013 · Cited by 109
du Bois, A., Herrstedt, J., Bessard, A. C. H., Müller, H.-H., Harter, P., Kristensen, G. B., Joly, F., Huober, J., Åvall-Lundqvist, E. H., Weber, B. E., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4696 · Cited by 109
Tropé, C., Kærn, J., Högberg, T., Abeler, V. M., Hagen, B., Kristensen, G. B., Onsrud, M., Pettersen, E. O., Rosenberg, P., Sandvei, R., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008399414923 · Cited by 108
Hoskins, P. J., Vergote, I. B., Cervantes, A. M. R., Tu, D., Stuart, G. C. E., Zola, P., Poveda, A. M., Provencher, D. M., Katsaros, D., Ojeda, B., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq362 · Cited by 91
Self-citationReview: Practical considerations in ovarian cancer chemotherapy
Cristea, M. C., Han, E. S., Salmon, L., & Morgan, R. J. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010361333 · Cited by 89
Self-citationFerriss, J. S., Java, J., Bookman, M. A., Fleming, G. F., Monk, B. J., Walker, J. L., Homesley, H. D., Fowler, J. M., Greer, B. E., Boente, M. P., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.07.103 · Cited by 83
Möbus, V. J., Wandt, H., Frickhofen, N., Bengala, C., Champion, K. M., Kimmig, R., Ostermann, H., Hinke, A., & Ledermann, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7527 · Cited by 83
Burger, R. A., Brady, M. F., Bookman, M. A., Monk, B. J., Walker, J. L., Homesley, H. D., Fowler, J. M., Greer, B. E., Boente, M. P., Fleming, G. F., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6524 · Cited by 82
Taylor, A., Wiltshaw, E., Gore, M. E., Fryatt, I., & Fisher, C. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2066 · Cited by 77
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
Winter-Roach, B. A., Kitchener, H. C., & Dickinson, H. O. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004706.pub3 · Cited by 76
Monk, B. J., Huang, H. Q., Burger, R. A., Mannel, R. S., Homesley, H. D., Fowler, J. M., Greer, B. E., Boente, M. P., Liang, S. X., & Wenzel, L. B. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.11.038 · Cited by 74
Laparoscopy and Ovarian Cancer: A Paradigm Change in the Management of Ovarian Cancer?
Liu, C. S., Nagarsheth, N. P., & Nezhat, F. R. (2009) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2009.01.007 · Cited by 63
González-Martı́n, A., Oza, A. M., Embleton-Thirsk, A., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, É., Kristensen, G. B., Bertrand, M. A., Beale, P. J., Cervantes, A. M. R., et al. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.08.036 · Cited by 63
Bogani, G., Borghi, C., Maggiore, U. L. R., et al. (2017) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2017.02.013 · Cited by 62
Laparoscopic staging for apparent stage I epithelial ovarian cancer
Melamed, A., Keating, N. L., Clemmer, J. T., Bregar, A. J., Wright, J. D., Boruta, D. M., Schorge, J. O., Carmen, M. G. D., & Rauh‐Hain, J. A. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.08.030 · Cited by 60
All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer
Melamed, A., Rizzo, A. E., Nitecki, R., Gockley, A. A., Bregar, A. J., Schorge, J. O., Carmen, M. G. D., & Rauh‐Hain, J. A. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002102 · Cited by 60
Treatment of Ovarian Cancer in Young Women
Gershenson, D. M. (2012) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e318248045b · Cited by 59
Self-citationSpriggs, D. R., Brady, M. F., Vaccarello, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3846 · Cited by 57
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature
Alletti, S. G., Capozzi, V. A., Rosati, A., Blasis, I. D., Cianci, S., Vizzielli, G., Uccella, S., Gallotta, V., Fanfani, F., Fagotti, A., et al. (2019) · Minerva Medica · doi:10.23736/s0026-4806.19.06132-9 · Cited by 53
Banerjee, S. N., Rustin, G. J. S., Paul, J., Williams, C., Pledge, S., Gabra, H., Skailes, G., Lamont, A., Hindley, A. C., Goss, G., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds494 · Cited by 51
Impact of initial surgical access on staging and survival of patients with stage I ovarian cancer
Lecuru, F. R., Desfeux, P., Camatte, S., Bissery, A., Blanc, B., & Querleu, D. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00303.x · Cited by 45
Liu, D., Cai, J., Gao, A., Wang, Z., & Cai, L. (2020) · BMC Cancer · doi:10.1186/s12885-020-06828-y · Cited by 45
Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer
Medeiros, L. R., Rosa, D. D., Bozzetti, M. C., da Rosa, M. I., Edelweiss, M. I. A., Stein, A. T., Zelmanowicz, A. D. M., Ethur, A. B. D. M., & Zanini, R. R. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005344.pub2 · Cited by 44
Rimel, B. J., Burke, W. M., Higgins, R. V., Lee, P. S., Lutman, C. V., & Parker, L. P. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.02.021 · Cited by 38
Fertility-Sparing Surgery for Borderline Ovarian Tumors
Song, T., Choi, C. H., Park, H. S., Kim, M. K., Lee, Y.-Y., Kim, T., Lee, Y.-Y., Bae, D., Kim, B., Song, T., et al. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182129842 · Cited by 38
Burger, R. A., Enserro, D. M., Tewari, K. S., Brady, M. F., Bookman, M. A., Fleming, G. F., Huang, H. Q., Homesley, H. D., Fowler, J. M., Boente, M. P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.5517 · Cited by 37
Gouy, S., Belghiti, J., Uzan, C., Canlorbe, G., Gauthier, T., & Morice, P. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182a616a7 · Cited by 35
Oshita, T., Itamochi, H., Nishimura, R., Numa, F., Takehara, K., Hiura, M., Tanimoto, H., Noma, J., Hayase, R., Murakami, A., et al. (2012) · International Journal of Clinical Oncology · doi:10.1007/s10147-012-0483-8 · Cited by 35
Brockbank, E. C., Harry, V. N., Kolomainen, D., Mukhopadhyay, D., Sohaib, A., Bridges, J. E., Nobbenhuis, M., Shepherd, J. H., Ind, T. E. J., & Barton, D. P. J. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.05.007 · Cited by 33
Lindemann, K. Y., Christensen, R. D., Vergote, I. B., Stuart, G. C. E., Izquierdo, M. A., Kærn, J., Havsteen, H., Eisenhauer, E. A., Ridderheim, M., Lopez, A. B., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds060 · Cited by 33
Self-citationMajor clinical research advances in gynecologic cancer in 2014
Suh, D. H., Lee, K.-H., Kim, K., Kang, S., & Kim, J. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2015.26.2.156 · Cited by 33
van de Vrie, R., van Meurs, H. S., Rutten, M. J., Naaktgeboren, C. A., Opmeer, B. C., Gaarenstroom, K. N., Gorp, T. V., ter Brugge, H. G., Hofhuis, W., Schreuder, H. W. R., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.06.019 · Cited by 31
Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
Elit, L. M., & Hirte, H. W. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s30238 · Cited by 30
Seidman, J. D., VANG, R. S., Ronnett, B. M., Yemelyanova, A. V., & Cosin, J. A. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.018 · Cited by 29
Duska, L., Java, J., Cohn, D. E., & Burger, R. A. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.08.011 · Cited by 28
Strategies for Introducing Outpatient Specialty Palliative Care in Gynecologic Oncology
Hay, C. M., Lefkowits, C., Crowley‐Matoka, M., Bakitas, M. A., Clark, L. H., Duska, L., Urban, R. R., Creasy, S. L., & Schenker, Y. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.020818 · Cited by 26
Ceccaroni, M., Roviglione, G., Bruni, F., et al. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5899-9 · Cited by 26
Jochum, F., Vermel, M., Faller, É., Boisramé, T., Lecointre, L., & Akladios, C. Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082507 · Cited by 25
Cytoreductive surgery for advanced ovarian cancer: quo vadis?
Schorge, J. O., Garrett, L. A., & Goodman, A. (2011) · PubMed · Cited by 21
Update on nonhormonal approaches to menopausal management.
Jenkins, M., & Sikon, A. L. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.suppl_4.s17 · Cited by 16
Tozzi, R., Gubbala, K., majd, H. S., & Campanile, R. G. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.003 · Cited by 16
Behbehani, S., Suárez-Salvador, E., Buras, M. R., Magtibay, P. M., & Magrina, J. F. (2019) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.06.017 · Cited by 16
Current management of menopausal symptoms in cancer patients.
Barton, D. L., Loprinzi, C. L., & Gostout, B. S. (2002) · PubMed · Cited by 15
Radosa, J. C., Radosa, M. P., Schweitzer, P., Juhasz-Böess, I., Rimbach, S., & Solomayer, E. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4709-5 · Cited by 10
Cited by
Mao, W., Chen, W., & Wang, Y. (2024) · Technology and Health Care · doi:10.3233/thc-230735 · Cited by 29
“…the most common psychological disorders for cancer patients, and cancer-related fatigue (CRF) would exert a great impact on the ability of cancer patients to cope with their disease as the sixth most important vital sign, and may aggravate the progression of EOC and affect disease prognosis [4].”
Background
Metadata
- Authors
- Armstrong, D. K., Alvarez, R. D., Bakkum-Gamez, J. N., Barroilhet, L., Behbakht, K., Berchuck, A., Chen, L.-M., Cristea, M., DeRosa, M., Eisenhauer, E. L., Gershenson, D. M., Gray, H. J., Grisham, R., Hakam, A., Jain, A., Karam, A., Konecny, G. E., Leath, C. A., Liu, J., Mahdi, H., Martin, L., Matei, D., McHale, M., McLean, K., Miller, D. S., O’Malley, D. M., Percac-Lima, S., Ratner, E., Remmenga, S. W., Vargas, R., Werner, T. L., Zsiros, E., Burns, J. L., & Engh, A. M.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2021-02
- Volume
- 19
- Issue
- 2
- Pages
- 191-226
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W3201437718
- Cited by
- 715
- References
- 134
- FWCI
- 91.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.